CreditReports.dk
HomeScreen companies

BIODANE PHARMA A/S Financials, key figures and credit report

CVR number: 28310102 Established 2004 Industry: 10 Manufacture of food products
Company contact details
Staushedevejen 10, 6621 Gesten tel: 75557411 https://biodanepharma.com/
Gross profit 2 534.2 kDKK FY 2025 -12.2% vs 2024
EBIT 30.5 kDKK FY 2025 -98.3% vs 2024
Net debt 545.9 kDKK FY 2025 +287.6% vs 2024
Quick ratio 2.6 FY 2025 -0.1 vs 2024

Company information

Official name
BIODANE PHARMA A/S
Established
2004
Company form
Limited company
Industry

Data sources and methodology

The information about BIODANE PHARMA A/S combines official Danish company and financial-statement data with indicators calculated by Valuatum Oy.

Company information

Name, CVR number, address, industry and legal form are based on the Danish Central Business Register (CVR).

CVR / Virk

Annual accounts

Financial figures come from annual reports published through the Danish Business Authority. The latest financial year used is 2025.

Open the 2025 annual report

Key figures and credit risk

Valuatum Oy calculates financial ratios, comparisons and credit-risk indicators from the available accounts. The results support analysis and do not constitute a standalone credit decision.

Valuatum Oy

About BIODANE PHARMA A/S

BIODANE PHARMA A/S (CVR number: 2831010-2) is a company from VEJEN. The company recorded a gross profit of 2534.2 kDKK in 2025. The operating profit was 30.5 kDKK, while net earnings were 182.9 kDKK. The profitability of the company measured by Return on Assets (ROA) was 7.6 %, which can be considered decent and Return on Equity (ROE) was 7.6 %, which can be considered decent. The equity ratio, a key indicator for solidity, stood at 67.6 %, a level that can be considered to be good. This shows that a large part of the company's assets are funded by shareholders' equity, reducing financial risk. BIODANE PHARMA A/S's liquidity measured by quick ratio was 2.6 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.

Financial information

See financials

Gross profit (kDKK)

EBIT (kDKK)

Profitability

Solidity

Key figures (kDKK)

See financials
2021
2022
2023
2024
2025
Volume
Net sales
Gross profit3 701.322 371.673 070.742 886.142 534.17
EBIT2 359.95616.23878.941 800.9630.55
Net earnings1 897.65586.35900.251 651.36182.86
Shareholders equity total4 056.164 642.523 542.762 322.142 505.00
Balance sheet total (assets)5 033.425 350.574 282.683 436.503 704.53
Net debt- 750.00426.44- 215.46140.85545.94
Profitability
EBIT-%
ROA65.9 %15.1 %24.4 %55.9 %7.6 %
ROE61.1 %13.5 %22.0 %56.3 %7.6 %
ROI79.2 %17.1 %26.8 %67.0 %8.9 %
Economic value added (EVA)1 732.30276.84429.871 219.37- 114.25
Solvency
Equity ratio80.6 %86.8 %82.7 %67.6 %67.6 %
Gearing9.6 %4.1 %18.3 %36.4 %
Relative net indebtedness %
Liquidity
Quick ratio4.97.15.42.72.6
Current ratio5.27.65.83.13.1
Cash and cash equivalents750.0019.59361.79284.49366.44
Capital use efficiency
Trade debtors turnover (days)
Net working capital %

Variable visualization

ROA FY 2025
7.64%
Rating 50/100
-20%
0%
4%
11%
24%
60%
Graph showing the distribution of the variable
Equity ratio FY 2025
67.6%
Rating 51/100
-1%
21%
50%
81%
99%
100%
Graph showing the distribution of the variable

Credit Risk Report

Affordable credit risk report
for basic company risk checks.

Check the creditworthiness of BIODANE PHARMA A/S before offering payment terms. The report combines financial figures, risk scores, credit rating, bankruptcy risk and a credit-limit recommendation in one PDF.

AI Credit Risk Report

The core credit-risk figures,
explained with AI.

The AI Credit Risk Report contains the same core financial figures and risk measures as the Credit Risk Report. It also provides written analysis of the company's finances, risks, repayment capacity and assets, together with relevant context from web searches.

  1. 01 Includes the same financial figures, risk scores, credit rating and bankruptcy risk as the Credit Risk Report.
  2. 02 AI complements the analysis with web searches and brings in the relevant company and operating-environment observations.
  3. 03 The written analysis is more precise, more readable and better suited to decision-making.
€3 / report

Company-specific, AI-assisted credit risk report in PDF format.

For larger customers

Reports can be tailored to your own credit process: content structure, peer groups, risk thresholds, delivery method and AI-analysis weightings can all be adapted to your needs.
Ask about a tailored solution: contact@creditreports.dk

The report is intended for an initial financial assessment. · The final credit decision and any further verification are always the user's responsibility. · One-time payment, no subscription.

What the report includes

8 sections
Financial figures
Risk scores
Credit rating
Bankruptcy risk
AI web-search highlights
Written risk analysis
Conclusions
Ratio appendices

Roles

Companies in the same industry

Page generated